Micro Ingredients squeaked ahead of most of the competition for a few reasons
GLP-3 style medications, also called triple agonists, are being studied because they may activate GLP-1, GIP, and glucagon pathways
A limitation of this study is the small sample size, with only n = 2 and n = 3 in two independent experiments, which may limit the statistical power and generalizability of these results
While exact dosing varies, the microdosing GLP-1 approach generally includes: Starting with a lower dose than standard treatment (such as Ozempic or Mounjaro) to allow the body to adjust Gradual adjustments over time based on tolerance, appetite changes, and results Monitoring appetite, digestion, and energy levels to guide dosing decisions Tracking weight and overall progress to ensure the approach is effective Because GLP-1 medications affect metabolism and blood sugar, this approach should always be individualized
Theyre also expensive without insurance more than $1,000 per month
In certain embodiments, the enhanced viscosity formulation is characterized by a phase transition between room temperature and body temperature (including an individual with a serious fever, e.g., up to about 42 C.)
